EFFICACY AND SAFETY OF ROZANOLIXIZUMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY (MYCARING)

被引：0

作者：

Bril, Vera ^{[1
]}

Druzdz, Artur ^{[2
]}

Grosskreutz, Julian ^{[3
]}

Habib, Ali A. ^{[4
]}

Mantegazza, Renato ^{[5
]}

Sacconi, Sabrina ^{[6
]}

Utsugisawa, Kimiaki ^{[7
]}

Vissing, John ^{[8
]}

Vu, Tuan ^{[9
]}

Boehnlein, Marion ^{[10
]}

Woltering, Franz ^{[10
]}

Bozorg, Ali ^{[11
]}

Gayfieva, Maryam ^{[12
]}

Kaminski, Henry ^{[13
]}

机构：

[1] Univ Hlth Network, Toronto, ON, Canada

[2] Municipal Hosp Poznan, Poznan, Poland

[3] Univ Lubeck, Dept Neurol, Leubeck, Germany

[4] Univ Calif Irvine, MDA ALS & Neuromuscular Ctr, Irvine, CA USA

[5] Fdn IRCCS, Ist Nazl Neurol Carlo Besta, Milan, Italy

[6] Univ Cote dAzur, CHU Nice, Peripheral Nervous Syst & Muscle Dept, Pasteur 2 Hosp, Nice, France

[7] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan

[8] Univ Copenhagen, Rigshosp, Dept Neurol, Copenhagen, Denmark

[9] Univ S Florida, Morsani Coll Med, Dept Neurol, Tampa, FL 33620 USA

[10] UCB Pharma, Monheim, Germany

[11] UCB Pharma, Morrisville, NC USA

[12] UCB Pharma, Slough, Berks, England

[13] George Washington Univ, Washington, DC 20052 USA

来源：

MUSCLE & NERVE | 2022年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S35 / S35

页数：1

共 50 条

[1] Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
Bril, Vera
Druzdz, Artur
Grosskreutz, Julian
Habib, Ali A.
Mantegazza, Renato
Sacconi, Sabrina
Utsugisawa, Kimiaki
Vissing, John
Vu, Tuan
Boehnlein, Marion
Bozorg, Ali
Gayfieva, Maryam
Greve, Bernhard
Woltering, Franz
Kaminski, Henry J.
[J]. LANCET NEUROLOGY, 2023, 22 (05): : 383 - 394
[2] PATIENT-REPORTED AND QUALITY OF LIFE OUTCOMES FROM MYCARING, A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL OF ROZANOLIXIZUMAB IN GENERALISED MYASTHENIA GRAVIS
Habib, Ali A.
Druzdz, Artur
Grosskreutz, Julian
Kaminski, Henry
Mantegazza, Renato
Sacconi, Sabrina
Utsugisawa, Kimiaki
Vissing, John
Vu, Tuan
Morel, Thomas
Boehnlein, Marion
Woltering, Franz
Bozorg, Ali
Gayfieva, Maryam
Bril, Vera
[J]. MUSCLE & NERVE, 2022, 65 : S19 - S20
[3] Efficacy of Rozanolixizumab in Generalized Myasthenia Gravis: Subgroup Analyses from the Randomized Phase 3 MycarinG Study
Vu, Tuan
Druzdz, Artur
Grosskreutz, Julian
Habib, Ali A.
Kaminski, Henry J.
Mantegazza, Renato
Utsugisawa, Kimiaki
Vissing, John
Beau-Lejdstrom, Raphaelle
Boehnlein, Marion
Gasalla, Teresa
Grimson, Fiona
Tarancon, Thais
Bril, Vera
[J]. NEUROLOGY, 2023, 100 (17)
[4] A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
Howard, James F., Jr.
Barohn, Richard J.
Cutter, Gary R.
Freimer, Miriam
Juel, Vern C.
Mozaffar, Tahseen
Mellion, Michelle L.
Benatar, Michael G.
Farrugia, Maria Elena
Wang, Jing Jing
Malhotra, Suneil S.
Kissel, John T.
[J]. MUSCLE & NERVE, 2013, 48 (01) : 76 - 84
[5] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY OF SUBCUTANEOUS BATOCLIMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
Nowak, Richard J.
Benatar, Michael
Breiner, Ari
Isaacman, Daniel J.
Bril, Vera
[J]. MUSCLE & NERVE, 2022, 65 : S21 - S21
[6] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER, MULTICENTER, PHASE II STUDY OF ECULIZUMAB IN PATIENTS WITH REFRACTORY GENERALIZED MYASTHENIA GRAVIS (GMG)
Howard, J. F.
Barohn, R.
Cutter, G.
Freimer, M.
Juel, V.
Mozaffar, T.
Mellion, M.
Benatar, M.
Farragia, M.
Pulley, M.
Gorson, K.
Chaudry, V.
Pascuzzi, R.
Siddiqi, Z.
Kissell, J. T.
[J]. MUSCLE & NERVE, 2011, 44 (04) : 689 - 690
[7] Randomized, Double-Blind, Placebo-Controlled, Crossover, Multicenter, Phase II Study of Eculizumab in Patients with Refractory Generalized Myasthenia Gravis (gMG)
Howard, James
Barohn, Richard
Freimer, Miriam
Juel, Vern
Mozaffar, Tahseen
Mellion, Michelle
Benatar, Michael
Farrugia, Maria
Kissel, John
[J]. NEUROLOGY, 2012, 78
[8] A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis
Strijbos, Ellen
Tannemaat, Martijn R.
Alleman, Iris
de Meel, Robert H. P.
Bakker, Jaap A.
van Beek, Ruud
Kroon, Frank P.
Rimmelzwaan, Guus F.
Verschuuren, Jan J. G. M.
[J]. VACCINE, 2019, 37 (07) : 919 - 925
[9] ROZANOLIXIZUMAB IN GENERALIZED MYASTHENIA GRAVIS: RESPONDER ANALYSES FROM THE RANDOMIZED PHASE 3 MYCARING STUDY
Bril, Vera
Druzdz, Artur
Grosskreutz, Julian
Habib, Ali
Mantegazza, Renato
Sacconi, Sabrina
Utsugisawa, Kimiaki
Vissing, John
Vu, Tuan
Boehnlein, Marion
Bozorg, Ali
Gayfieva, Maryam
Woltering, Franz
Kaminski, Henry
[J]. MUSCLE & NERVE, 2022, 66 : S112 - S112
[10] Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
Howard Jr, James F.
Bresch, Saskia
Genge, Angela
Hewamadduma, Channa
Hinton, John
Hussain, Yessar
Juntas-Morales, Raul
Kaminski, Henry J.
Maniaol, Angelina
Mantegazza, Renato
Masuda, Masayuki
Sivakumar, Kumaraswamy
Smilowski, Marek
Utsugisawa, Kimiaki
Vu, Tuan
Weiss, Michael
Zajda, Malgorzata
Boroojerdi, Babak
Brock, Melissa
de la Borderie, Guillemette
Duda, Petra W.
Lowcock, Romana
Vanderkelen, Mark
Leite, M. Isabel
[J]. LANCET NEUROLOGY, 2023, 22 (05): : 395 - 406

← 1 2 3 4 5 →